Related Experiment Video
Updated: Jun 19, 2026

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational
1Division of Gerontology and Geriatrics & Center for Musculoskeletal Research, Leuven University Department of Experimental Medicine, Leuven, Belgium. steven.boonen@uz.kuleuven.ac.be
Bisphosphonates effectively reduce fracture risk in postmenopausal women. Evaluating randomized controlled trials and observational studies provides a comprehensive understanding of their anti-fracture efficacy.
Area of Science:
- Osteoporosis Research
- Pharmacological Efficacy Studies
Background:
- Osteoporosis treatment efficacy is assessed via diverse study designs.
- Bisphosphonates are a key therapeutic class for osteoporosis management.
Purpose of the Study:
- To review evidence on bisphosphonate anti-fracture efficacy in postmenopausal women.
- To discuss strengths and limitations of various study methodologies.
Main Methods:
- Literature review of randomized controlled trials (RCTs), meta-analyses, and observational studies.
- Included studies evaluated alendronate, ibandronate, risedronate, and zoledronate.
- Studies required >100 patients and ≥1 year follow-up.
Main Results:
- RCT data indicate varying site-specific efficacy and onset of fracture risk reduction among bisphosphonates.
- Observational studies show mixed results on clinical outcomes.
- Sustained fracture protection observed up to 10 years (alendronate) and 7 years (risedronate).
Conclusions:
- Integrating RCT and observational data maximizes understanding of bisphosphonate benefits.
- Bisphosphonates demonstrate fracture risk reduction in both clinical trials and real-world settings.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...